跳至主要内容
临床试验/CTRI/2021/08/035626
CTRI/2021/08/035626尚未招募未知

Effectiveness, safety and tolerability of standard dose of Bilastine and updosed Bilastine for the treatment of uncontrolled chronic spontaneous urticaria

Dr Sankha Subhra Chakraborty0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • INCLUSION CRITERIA:
  • Male or female patients 18-65 years (both inclusive)
  • Patients having uncontrolled chronic spontaneous urticaria UAS score>=7(urticaria activity score ),after being treated with H1 antihistamine in standard dose(other than BILASTINE).

排除标准

  • Acute urticria, Physical urticaria, chronic Inducible urticaria,contact urticaria
  • Systemic diseases and infections
  • Herediary angioedema,atopic dermatitis
  • Preganancy and lactation
  • Known hypersensivity to Bilastine
  • Corticosteroid use (systemic/topical) in recent times for same condition

研究者

发起方
Dr Sankha Subhra Chakraborty

相似试验